Advanced company searchLink opens in new window

GENZYME THERAPEUTICS LIMITED

Company number 04316333

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
06 Jul 2024 AA Full accounts made up to 31 December 2023
03 Mar 2024 AP01 Appointment of Rippon Ubhi as a director on 1 March 2024
01 Mar 2024 TM01 Termination of appointment of Jessamy Rachel Baird as a director on 1 March 2024
02 Feb 2024 CS01 Confirmation statement made on 31 December 2023 with no updates
18 Jul 2023 AA Full accounts made up to 31 December 2022
06 Jan 2023 CS01 Confirmation statement made on 31 December 2022 with no updates
14 Oct 2022 AP01 Appointment of Ms Jessamy Rachel Baird as a director on 1 October 2022
14 Oct 2022 TM01 Termination of appointment of Nicole Suzanne Farmer as a director on 1 October 2022
15 Jul 2022 AA Full accounts made up to 31 December 2021
07 Feb 2022 CS01 Confirmation statement made on 31 December 2021 with no updates
28 Jul 2021 AA Full accounts made up to 31 December 2020
08 Apr 2021 AP01 Appointment of Mr Usman Khan as a director on 31 March 2021
07 Apr 2021 AA Full accounts made up to 31 December 2019
03 Apr 2021 TM01 Termination of appointment of Francois-Xavier Duhalde as a director on 31 March 2021
11 Mar 2021 CS01 Confirmation statement made on 31 December 2020 with updates
02 Jun 2020 AP01 Appointment of Ms Nicole Suzanne Farmer as a director on 16 May 2020
29 May 2020 TM01 Termination of appointment of Peter Sjoerd Kuiper as a director on 16 May 2020
13 Jan 2020 CS01 Confirmation statement made on 31 December 2019 with updates
09 Oct 2019 AA Full accounts made up to 31 December 2018
03 Oct 2019 PSC05 Change of details for Aventis Pharma Limited as a person with significant control on 15 July 2019
15 Jul 2019 AD01 Registered office address changed from 4620 Kingsgate Cascade Way Oxford Business Park South Oxford Oxfordshire OX4 2SU to 410 Thames Valley Park Drive Reading Berkshire RG6 1PT on 15 July 2019
14 May 2019 PSC02 Notification of Aventis Pharma Limited as a person with significant control on 30 April 2019
14 May 2019 PSC07 Cessation of Sanofi-Aventis Uk Holdings Limited as a person with significant control on 30 April 2019
08 Feb 2019 AA Full accounts made up to 31 December 2017
12 Jan 2019 DISS40 Compulsory strike-off action has been discontinued